Highlights from the 4th EUTROC meeting: Prof John Green – University of Liverpool, UK

Development of clinical trials and bio banks: Prof Hani Gabra – Imperial College London, UK

Drug approval process for ovarian cancer: Prof Maria Paolo Costi – University of Modena, Italy

Biology of molecular sub types in ovarian cancer: Prof David Bowtell – Peter MacCallum Cancer Centre, Melbourne, Australia

Interplay between pathologies of ovarian cancer and genomics: Prof David Huntsman – University of British Columbia, Canada

Histological and molecular sub types of ovarian cancer: Dr Jozien Helleman – Erasmus Medical Centre, Rotterdam, Netherlands

Interaction between tumour biology and surgery: Dr Christina Fotopoulou – Charite University Hospital, Berlin, Germany

Early stage biomarkers in ovarian cancer: Prof Angelo Paradiso – National Cancer Research Institute, Bari, Italy

Sub-typing ovarian cancer: Dr Charles Gourley – University of Edinburgh Cancer Research Center, UK

The Merseyside and Cheshire cancer network: Dr John Kirwan – Liverpool Womens Hospital, UK